Triple-negative breast cancer (TNBC) is a heterogeneous disease defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression and human epithelial growth factor receptor 2 (HER2) amplification. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.